A dysregulated MicroRNA-26a/EphA2 axis impairs endothelial progenitor cell function via the p38 MAPK/VEGF pathway

Cellular Physiology and Biochemistry

Volumn 35, Issue 2, 2015, Pages 477-488

  Zuo, Keqiang ^a   Zhi, Kangkang ^b   Zhang, Xiaoping ^a   Lu, Chenghui ^a   Wang, Shi ^a   Li, Maoquan ^a   He, Bin ^c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Endothelial progenitor cell function; EphA2; MicroRNA 26a; p38 MAPK VEGF pathway

Indexed keywords

EPHRIN RECEPTOR A2; MICRORNA 26A; MITOGEN ACTIVATED PROTEIN KINASE P38; VASCULOTROPIN; MICRORNA; MIRN26A MICRORNA, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BONE MARROW; CELL HYPOXIA; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MALE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BINDING SITE; BLOOD; CELL MOTION; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; GENE SILENCING; GENETICS; METABOLISM; MOUSE; MUTATION; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; BINDING SITES; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIAL PROGENITOR CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICRORNAS; MUTATION; RATS; RECEPTOR, EPHA2; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84921893887     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000369713     Document Type: Article

References (58)

1. Hansson GK, Libby P: The immune response in atherosclerosis: A double-edged sword. Nat Rev Immunol 2006; 6: 508-519.
2. Glass CK, Witztum JL: Atherosclerosis. The road ahead. Cell 2001; 104: 503-516.
3. Huang S, Tang Y, Cai X, Peng X, Liu X, Zhang L, Xiang Y, Wang D, Wang X, Pan T: Celastrol inhibits vasculogenesis by suppressing the vegf-induced functional activity of bone marrow-Derived endothelial progenitor cells. Biochem Biophys Res Commun; 423: 467-472.
4. Sluimer JC, Daemen MJ: Novel concepts in atherogenesis: Angiogenesis and hypoxia in atherosclerosis. J Pathol 2009; 218: 7-29.
5. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJ, Verma S: Endothelial progenitor cells: New hope for a broken heart. Circulation 2003; 107: 3093-3100.
6. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 3422-3427.
7. Shukla GC, Singh J, Barik S: Micrornas: Processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol; 3: 83-92.
8. Pasquinelli AE: Micrornas and their targets: Recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet; 13: 271-282.
9. Kloosterman WP, Plasterk RH: The diverse functions of micrornas in animal development and disease. Dev Cell 2006; 11: 441-450.
10. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Zen K, Zhang CY: Characterization of micrornas in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
11. Zhang C: Micrornas: Role in cardiovascular biology and disease. Clin Sci (Lond) 2008; 114: 699-706.
12. Latronico MV, Catalucci D, Condorelli G: Emerging role of micrornas in cardiovascular biology. Circ Res 2007; 101: 1225-1236.
13. Urbich C, Kuehbacher A, Dimmeler S: Role of micrornas in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008; 79: 581-588.
14. Yang X, Zhang XF, Lu X, Jia HL, Liang L, Dong QZ, Ye QH, Qin LX: Microrna-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cmet pathway. Hepatology; 59: 1874-1885.
15. Qian X, Zhao P, Li W, Shi ZM, Wang L, Xu Q, Wang M, Liu N, Liu LZ, Jiang BH: Microrna-26a promotes tumor growth and angiogenesis in glioma by directly targeting prohibitin. CNS Neurosci Ther; 19: 804-812.
16. Chai ZT, Kong J, Zhu XD, Zhang YY, Lu L, Zhou JM, Wang LR, Zhang KZ, Zhang QB, Ao JY, Wang M, Wu WZ, Wang L, Tang ZY, Sun HC: Microrna-26a inhibits angiogenesis by down-regulating vegfa through the pik3c2alpha/akt/hif-1alpha pathway in hepatocellular carcinoma. PLoS One; 8: e77957.
17. Icli B, Wara AK, Moslehi J, Sun X, Plovie E, Cahill M, Marchini JF, Schissler A, PaDera RF, Shi J, Cheng HW, Raghuram S, Arany Z, Liao R, Croce K, MacRae C, Feinberg MW: Microrna-26a regulates pathological and physiological angiogenesis by targeting bmp/smad1 signaling. Circ Res; 113: 1231-1241.
18. Pasquale EB: The eph family of receptors. Curr Opin Cell Biol 1997; 9: 608-615.
19. Easty DJ, Bennett DC: Protein tyrosine kinases in malignant melanoma. Melanoma Res 2000; 10: 401-411.
20. Zelinski DP, Zantek ND, Stewart JC, Irizarry AR, Kinch MS: Epha2 overexpression causes tumorigenesis of mammary epithelial cells. Cancer Res 2001; 61: 2301-2306.
21. Walker-Daniels J, Coffman K, Azimi M, Rhim JS, Bostwick DG, SnyDer P, Kerns BJ, Waters DJ, Kinch MS: Overexpression of the epha2 tyrosine kinase in prostate cancer. Prostate 1999; 41: 275-280.
22. D'Amico TA, Aloia TA, Moore MB, Conlon DH, Herndon JE, 2nd, Kinch MS, Harpole DH, Jr.: Predicting the sites of metastases from lung cancer using molecular biologic markers. Ann Thorac Surg 2001; 72: 1144-1148.
23. Ogawa K, Pasqualini R, Lindberg RA, Kain R, Freeman AL, Pasquale EB: The ephrin-a1 ligand and its receptor, epha2, are expressed during tumor neovascularization. Oncogene 2000; 19: 6043-6052.
24. Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J: Blockade of epha receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis. Mol Cancer Res 2002; 1: 2-11.
25. Lin YG, Han LY, Kamat AA, Merritt WM, Landen CN, Deavers MT, Fletcher MS, Urbauer DL, Kinch MS, Sood AK: Epha2 overexpression is associated with angiogenesis in ovarian cancer. Cancer 2007; 109: 332-340.
26. Funk SD, Orr AW: Ephs and ephrins resurface in inflammation, immunity, and atherosclerosis. Pharmacol Res; 67: 42-52.
27. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.
28. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA: Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004; 56: 549-580.
29. Wang HW, Lo HH, Chiu YL, Chang SJ, Huang PH, Liao KH, Tasi CF, Wu CH, Tsai TN, Cheng CC, Cheng SM: Dysregulated mir-361-5p/vegf axis in the plasma and endothelial progenitor cells of patients with coronary artery disease. PLoS One; 9: e98070.
30. Menghini R, Stohr R, FeDerici M: Micrornas in vascular aging and atherosclerosis. Ageing Res Rev; 17: 68-78.
31. Wei Y, Nazari-Jahantigh M, Neth P, Weber C, Schober A: Microrna-126,-145, and-155: A therapeutic triad in atherosclerosis? Arterioscler Thromb Vasc Biol; 33: 449-454.
32. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Koppel T, Jahantigh MN, Lutgens E, Wang S, Olson EN, Schober A, Weber C: Delivery of microrna-126 by apoptotic bodies induces cxcl12-dependent vascular protection. Sci Signal 2009; 2: ra81.
33. Sun X, Icli B, Wara AK, Belkin N, He S, Kobzik L, Hunninghake GM, Vera MP, Blackwell TS, Baron RM, Feinberg MW: Microrna-181b regulates nf-kappab-mediated vascular inflammation. J Clin Invest; 122: 1973-1990.
34. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF: Microrna-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci U S A; 107: 13450-13455.
35. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN: The endothelial-specific microrna mir-126 governs vascular integrity and angiogenesis. Dev Cell 2008; 15: 261-271.
36. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S: Microrna-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009; 324: 1710-1713.
37. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F: Microrna-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-a3. J Biol Chem 2008; 283: 15878-15883.
38. Chen Y, Gorski DH: Regulation of angiogenesis through a microrna (mir-130a) that down-regulates antiangiogenic homeobox genes gax and hoxa5. Blood 2008; 111: 1217-1226.
39. Zhou Q, Gallagher R, Ufret-Vincenty R, Li X, Olson EN, Wang S: Regulation of angiogenesis and choroidal neovascularization by members of microrna-23-27-24 clusters. Proc Natl Acad Sci U S A; 108: 8287-8292.
40. Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC: Dicer dependent micrornas regulate gene expression and functions in human endothelial cells. Circ Res 2007; 100: 1164-1173.
41. Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F, Vasa-Nicotera M, Ippoliti A, Novelli G, Melino G, Lauro R, FeDerici M: Microrna 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009; 120: 1524-1532.
42. Zhao T, Li J, Chen AF: Microrna-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab; 299: E110-116.
43. Luzi E, Marini F, Sala SC, Tognarini I, Galli G, Brandi ML: Osteogenic differentiation of human adipose tissue-Derived stem cells is modulated by the mir-26a targeting of the smad1 transcription factor. J Bone Miner Res 2008; 23: 287-295.
44. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sage C, Agami R, Tuschl T, Holland EC: The pten-regulating microrna mir-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009; 23: 1327-1337.
45. Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS, Spin JM: Microrna-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol; 226: 1035-1043.
46. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT: Therapeutic microrna delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005-1017.
47. SanDer S, Bullinger L, Wirth T: Repressing the repressor: A new mode of myc action in lymphomagenesis. Cell Cycle 2009; 8: 556-559.
48. Foubert P, Silvestre JS, Souttou B, Barateau V, Martin C, Ebrahimian TG, Lere-Dean C, Contreres JO, Sulpice E, Levy BI, Plouet J, Tobelem G, Le Ricousse-Roussanne S: Psgl-1-mediated activation of ephb4 increases the proangiogenic potential of endothelial progenitor cells. J Clin Invest 2007; 117: 1527-1537.
49. Hahn C, Schwartz MA: Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol 2009; 10: 53-62.
50. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
51. Dottori M, Hartley L, Galea M, Paxinos G, Polizzotto M, Kilpatrick T, Bartlett PF, Murphy M, Kontgen F, Boyd AW: Epha4 (sek1) receptor tyrosine kinase is required for the development of the corticospinal tract. Proc Natl Acad Sci U S A 1998; 95: 13248-13253.
52. Brantley-SieDers DM, Fang WB, Hwang Y, Hicks D, Chen J: Ephrin-a1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by epha receptor and vascular endothelial growth factor in mice. Cancer Res 2006; 66: 10315-10324.
53. Chen J, Hicks D, Brantley-SieDers D, Cheng N, McCollum GW, Qi-Werdich X, Penn J: Inhibition of retinal neovascularization by soluble epha2 receptor. Exp Eye Res 2006; 82: 664-673.
54. Baldwin C, Chen ZW, Bedirian A, Yokota N, Nasr SH, Rabb H, Lemay S: Upregulation of epha2 during in vivo and in vitro renal ischemia-reperfusion injury: Role of src kinases. Am J Physiol Renal Physiol 2006; 291: F960-971.
55. Zhou N, Zhao WD, Liu DX, Liang Y, Fang WG, Li B, Chen YH: Inactivation of epha2 promotes tight junction formation and impairs angiogenesis in brain endothelial cells. Microvasc Res; 82: 113-121.
56. Vihanto MM, Plock J, Erni D, Frey BM, Frey FJ, Huynh-Do U: Hypoxia up-regulates expression of eph receptors and ephrins in mouse skin. FASEB J 2005; 19: 1689-1691.
57. Gavard J, Gutkind JS: Vegf controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of ve-cadherin. Nat Cell Biol 2006; 8: 1223-1234.
58. Wong BW, Rahmani M, Luo Z, Yanagawa B, Wong D, Luo H, McManus BM: Vascular endothelial growth factor increases human cardiac microvascular endothelial cell permeability to low-density lipoproteins. J Heart Lung Transplant 2009; 28: 950-957.